Occult Hepatitis B Virus Infection in Immunized Infants Born to Untreated and Tenofovir-Treated Highly Viremic Mothers

Clin Gastroenterol Hepatol. 2021 Jul;19(7):1494-1496. doi: 10.1016/j.cgh.2020.07.041. Epub 2020 Jul 23.

Abstract

Tenofovir disoproxil fumurate (TDF) therapy during late pregnancy in highly viremic mothers can reduce residual overt hepatitis B virus (HBV) infections of their infants that occur despite immunoprophylaxis.1,2 Occult HBV infection (OBI) has been defined as the presence of HBV DNA in liver or sera in subjects seronegative for hepatitis B surface antigen (HBsAg).3 OBI has been found in varying proportions of immunized infants born to HBsAg-positive mothers.4-6 We aimed to investigate the impact of maternal TDF therapy during pregnancy on vertically acquired OBI.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • DNA, Viral
  • Female
  • Hepatitis B Surface Antigens
  • Hepatitis B virus* / genetics
  • Hepatitis B* / prevention & control
  • Humans
  • Infant
  • Infectious Disease Transmission, Vertical / prevention & control
  • Mothers
  • Pregnancy
  • Tenofovir / therapeutic use

Substances

  • DNA, Viral
  • Hepatitis B Surface Antigens
  • Tenofovir